{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:50:23Z","timestamp":1764874223117,"version":"3.41.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.aprim.2025.103234","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:19:19Z","timestamp":1739344759000},"page":"103234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescripci\u00f3n prolongada de antidepresivos en atenci\u00f3n primaria. Impacto en la salud p\u00fablica"],"prefix":"10.1016","volume":"57","author":[{"given":"Antonio Jos\u00e9","family":"Madue\u00f1o-Caro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Berro-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ch\u00e1vez-Gata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Torrescusa-Camis\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Climent-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Navarro-Abal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-7730","authenticated-orcid":false,"given":"Juan","family":"G\u00f3mez-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2025.103234_bib0155","unstructured":"Statista. Antidepressant consumption in selected countries 2020. Statista. Revisado en enero, 2022 [consultado 14 Ene 2025]. Disponible en: https:\/\/www.statista.com\/statistics\/283072\/antidepressant-consumption-in-selected-countries"},{"article-title":"Guidelines for ATC classification and DDD assignment","year":"2024","series-title":"2024","key":"10.1016\/j.aprim.2025.103234_bib0160"},{"key":"10.1016\/j.aprim.2025.103234_bib0165","unstructured":"OECD. Pharmaceutical market. Oecd.org. Recuperado el 12 de julio de 2022 [consultado 14 Ene 2025]. Disponible en: https:\/\/stats.oecd.org\/Index.aspx?DataSetCode=HEALTH_PHMC"},{"key":"10.1016\/j.aprim.2025.103234_bib0170","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia Espa\u00f1ola del Medicamento y Productor Sanitarios. Utilizaci\u00f3n de medicamentos antidepresivos en Espa\u00f1a durante el periodo 2000-2013. Gobierno de Espa\u00f1a. 2015 [consultado 14 Ene 2025]. Disponible en: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/antidepresivos-2000-2013.pdf"},{"key":"10.1016\/j.aprim.2025.103234_bib0175","doi-asserted-by":"crossref","unstructured":"Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch Gen Psychiatry. 1991;48:730-738 [consultado 14 Ene 2025]. Disponible en: https:\/\/doi.org\/10.1001\/archpsyc.1991.01810320054008","DOI":"10.1001\/archpsyc.1991.01810320054008"},{"key":"10.1016\/j.aprim.2025.103234_bib0180","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy","volume":"326","author":"Max","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2025.103234_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040822","article-title":"Strategies to treat chronic pain and strengthen impaired descending noradrenergic inhibitory system","volume":"20","author":"Hayashida","year":"2019","journal-title":"Int J Mol Sci"},{"year":"2024","series-title":"Tricyclic Antidepressants. In: StatPearls","author":"Moraczewski","key":"10.1016\/j.aprim.2025.103234_bib0190"},{"key":"10.1016\/j.aprim.2025.103234_bib0195","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision: Treatment of neuropathic pain","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"year":"2013","series-title":"Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings [Internet]","key":"10.1016\/j.aprim.2025.103234_bib0200"},{"key":"10.1016\/j.aprim.2025.103234_bib0205","article-title":"Psiquiatrizaci\u00f3n de la vida cotidiana. Disease Mongering en Salud Mental en A. Ansean","volume":"1","author":"Ansean Ramos","year":"2012","journal-title":"Manual de gesti\u00f3n cl\u00ednica y sanitaria de la Salud Mental"},{"key":"10.1016\/j.aprim.2025.103234_bib0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.genhosppsych.2008.05.001","article-title":"Major depression as a risk factor for chronic disease incidence: Longitudinal analyses in a general population cohort","volume":"30","author":"Patten","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.aprim.2025.103234_bib0215","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.aprim.2013.04.014","article-title":"Medicalizaci\u00f3n de la vida. Etiquetas de enfermedad: todo un negocio","volume":"45","author":"Cerecedo P\u00e9rez","year":"2013","journal-title":"Aten Primaria"},{"key":"10.1016\/j.aprim.2025.103234_bib0220","unstructured":"Servicio de Promoci\u00f3n de Uso Racional del Medicamento. Subdirecci\u00f3n de Farmacia y Prestaciones. Servicio Andaluz de Salud. Antidepresivos: selecci\u00f3n y deprescripci\u00f3n. Recomendaciones para el uso racional del medicamento en el tratamiento farmacol\u00f3gico de la salud mental. Junta de Andaluc\u00eda. 2022 [consultado 14 Ene 2025]. Disponible en: https:\/\/www.sspa.juntadeandalucia.es\/servicioandaluzdesalud\/profesionales\/farmacia-y-prestaciones\/uso-racional-del-medicamento"},{"key":"10.1016\/j.aprim.2025.103234_bib0225","first-page":"1285","article-title":"Update on COVID-19 and mental health [Article in Spanish]","volume":"13","author":"Rodr\u00edguez-Quiroga","year":"2020","journal-title":"Medicine (Madr)"},{"key":"10.1016\/j.aprim.2025.103234_bib0230","doi-asserted-by":"crossref","first-page":"pyv076","DOI":"10.1093\/ijnp\/pyv076","article-title":"Prevention of relapse and recurrence in adults with major depressive disorder: Systematic review and meta-analyses of controlled trials","volume":"19","author":"Sim","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.aprim.2025.103234_bib0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4321\/S0211-57352011000300003","article-title":"An\u00e1lisis comparativo de los pacientes con y sin trastorno mental diagnosticable","volume":"31","author":"Lozano Serrano","year":"2011","journal-title":"Rev Asoc Esp Neuropsiquiatr"},{"key":"10.1016\/j.aprim.2025.103234_bib0240","first-page":"CD012855","article-title":"Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults","volume":"5","author":"Machmutow","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2025.103234_bib0245","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments: Section 3. Pharmacological Treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.aprim.2025.103234_bib0250","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jad.2014.12.016","article-title":"Effectiveness of psychological interventions in preventing recurrence of depressive disorder: Meta-analysis and meta-regression","volume":"174","author":"Biesheuvel-Leliefeld","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.aprim.2025.103234_bib0255","unstructured":"National Institute for Health and Clinical Excellence. Depression: The treatment and management of depression in adults (Updated Edition). NICE clinical Guideline. 2009 [consultado 14 Ene 2025]. Disponible en: https:\/\/www.nice.org.uk\/guidance\/ng222"},{"key":"10.1016\/j.aprim.2025.103234_bib0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.aprim.2025.103234_bib0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.13r08722","article-title":"Review of maintenance trials for major depressive disorder: A 25-year perspective from the US Food and Drug Administration","volume":"75","author":"Borges","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.aprim.2025.103234_bib0270","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40263-014-0171-5","article-title":"Early switching strategies in antidepressant non-responders: Current evidence and future research directions","volume":"28","author":"Kudlow","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.aprim.2025.103234_bib0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302229","article-title":"Interventions promoting recovery from depression for patients transitioning from outpatient mental health services to primary care: A scoping review","volume":"19","author":"Aggestrup","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.aprim.2025.103234_bib0280","first-page":"9","article-title":"Evolution of the prevalence and incidence of consumption of antidepressants in a Spanish region (2002-2007)","volume":"7","author":"Serna","year":"2010","journal-title":"Ment Health Fam Med"},{"key":"10.1016\/j.aprim.2025.103234_bib0285","article-title":"Trajectories of acute antidepressant efficacy: How long to wait for response? A systematic review and meta-analysis of long-term, placebo-controlled acute treatment trials","volume":"79","author":"Henssler","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.aprim.2025.103234_bib0290","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.aprim.2025.103234_bib0295","article-title":"Psychological therapies for treatment-resistant depression in adults","volume":"5","author":"Ijaz","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2025.103234_bib0300","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/jamapsychiatry.2017.3047","article-title":"Adherence to depression treatment in primary care: A randomized clinical trial","volume":"74","author":"Sirey","year":"2017","journal-title":"JAMA Psychiatry"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656725000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656725000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:10:09Z","timestamp":1753708209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656725000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0212656725000204"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2025.103234","relation":{},"ISSN":["0212-6567"],"issn-type":[{"type":"print","value":"0212-6567"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescripci\u00f3n prolongada de antidepresivos en atenci\u00f3n primaria. Impacto en la salud p\u00fablica","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2025.103234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103234"}}